QGEN
Qiagen NV
NYSE: QGEN · HEALTHCARE · DIAGNOSTICS & RESEARCH
$33.61
-1.21% today
Updated 2026-04-29
Market cap
$6.93B
P/E ratio
16.48
P/S ratio
3.31x
EPS (TTM)
$2.04
Dividend yield
0.77%
52W range
$33 – $58
Volume
1.9M
Qiagen NV (QGEN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
20.30%
Operating margin
27.40%
ROE
11.60%
ROA
5.77%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $465.78M | $70.54M | 69.69% | 21.60% | 15.14% |
| 2007 | $649.77M | $50.12M | 66.72% | 12.79% | 7.71% |
| 2008 | $892.98M | $89.03M | 67.16% | 16.31% | 9.97% |
| 2009 | $1.01B | $137.77M | 66.06% | 17.85% | 13.64% |
| 2010 | $1.09B | $144.31M | 65.80% | 17.34% | 13.27% |
| 2011 | $1.17B | $96.04M | 64.10% | 8.51% | 8.21% |
| 2012 | $1.25B | $129.51M | 65.69% | 13.54% | 10.32% |
| 2013 | $1.30B | $69.07M | 62.63% | 4.86% | 5.31% |
| 2014 | $1.34B | $116.36M | 64.34% | 12.02% | 8.65% |
| 2015 | $1.28B | $130.15M | 64.53% | 14.01% | 10.16% |
| 2016 | $1.34B | $80.40M | 63.13% | 7.39% | 6.01% |
| 2017 | $1.42B | $40.39M | 65.08% | 10.82% | 2.85% |
| 2018 | $1.50B | $190.38M | 66.65% | 17.75% | 12.68% |
| 2019 | $1.53B | $-41.45M | 65.86% | -1.71% | -2.72% |
| 2020 | $1.87B | $359.19M | 65.91% | 20.66% | 19.20% |
| 2021 | $2.25B | $512.60M | 64.43% | 27.98% | 22.77% |
| 2022 | $2.14B | $423.21M | 64.65% | 24.82% | 19.76% |
| 2023 | $1.97B | $341.30M | 62.77% | 20.86% | 17.37% |
| 2024 | $1.98B | $83.59M | 48.90% | 4.94% | 4.23% |
| 2025 | $2.09B | $424.88M | 61.79% | 24.90% | 20.33% |